Back to Trades
Buy4
Eikon Therapeutics, Inc.
EIKN
Total Value
$38.1M
Net $38.1M bought
Purchases
$38.1M
3 transactions
Company Information
- Company Name
- Eikon Therapeutics, Inc.
- Ticker Symbol
- EIKN
- CIK
- 0001861123
Insider Information
- Role
- Insider
- Location
- SAN FRANCISCO, CA
Filing Details
- Filing Date
- Feb 9, 2026
- Transaction Date
- Feb 6, 2026
- Accession Number
- 0001193125-26-043320
- Form Type
- 4
- Net Trading Amount
- $38.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Common Stock | 1,296,629 | — | C | — |
| Feb 6, 2026 | Common Stock | 1,403,568 | — | C | — |
| Feb 6, 2026 | Common Stock | 110,928 | — | C | — |
| Feb 6, 2026 | Common Stock | 44,249 | — | C | — |
| Feb 6, 2026 | Common Stock | 47,898 | — | C | — |
| Feb 6, 2026 | Common Stock | 3,785 | — | C | — |
| Feb 6, 2026 | Common Stock | 688,283 | — | C | — |
| Feb 6, 2026 | Common Stock | 1,437,323 | $18.00 | Purchase | $25.9M |
| Feb 6, 2026 | Common Stock | 49,556 | $18.00 | Purchase | $892.0K |
| Feb 6, 2026 | Common Stock | 630,881 | $18.00 | Purchase | $11.4M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Derivative | 9,670,000 | — | C | — |
| Feb 6, 2026 | Derivative | 330,000 | — | C | — |
| Feb 6, 2026 | Derivative | 10,467,526 | — | C | — |
| Feb 6, 2026 | Derivative | 357,216 | — | C | — |
| Feb 6, 2026 | Derivative | 827,278 | — | C | — |
| Feb 6, 2026 | Derivative | 28,229 | — | C | — |
| Feb 6, 2026 | Derivative | 5,133,076 | — | C | — |
Footnotes
- (F1)Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of the Issuer's Common Stock and has no expiration date
- (F2)The shares are directly held by The Column Group IV, LP ("TCG IV LP"). The Column Group IV GP, LP ("TCG IV GP LP") is the general partner of TCG IV LP and may be deemed to have voting and investment power with respect to shares directly held by TCG IV LP. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG IV LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.
- (F3)The shares are directly held by The Column Group IV-A, LP ("TCG IV-A LP"). TCG IV GP LP is the general partner of the TCG IV-A LP and may be deemed to have voting and investment power with respect to shares directly held by the Reporting Person. Peter Svennilson and Tim Kutzkey are the managing partners of TCG IV GP LP and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG IV-A LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.
- (F4)The securities are directly held by The Column Group Opportunity III, LP ("TCG Opportunity III LP"). The Column Group Opportunity III GP, LP ("TCG Opportunity III GP LP") is the general partner of TCG Opportunity III LP. TCG Opportunity III GP, LLC is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP. Each of TCG Opportunity III GP LP and TCG Opportunity III GP, LLC may be deemed to have voting, investment and dispositive power with respect to securities directly held by TCG Opportunity III LP. Peter Svennilson and Tim Kutzkey are the managing members of TCG Opportunity III GP, LLC and may each be deemed to share voting, investment and dispositive power with respect to securities directly held by TCG Opportunity III LP. Each of the Reporting Persons disclaims beneficial ownership of the securities noted herein, except to the extent of its or his pecuniary interest therein.